Diagnosis and Treatment of Endocrine Disorders in the HIV-Infected Patient

Figure 6: Growth agents compared

From International Association of Physicians in AIDS Care

February, 1998

Comparisons of (A) serum insulin-like growth factor I (IGF-I) levels and (B) mean overnight growth hormone (GH) levels between patients with AIDS wasting and HIV-negative controls.

*P<.05 and P<.01, respectively.

Adapted from Grinspoon et al.² Reprinted with permission of the Journal of Clinical Endocrinology and Metabolism.

Back to the main article.

This article was provided by International Association of Physicians in AIDS Care. It is a part of the publication Journal of the International Association of Physicians in AIDS Care.

10 Questions to Ask Yourself Before You Begin HIV Treatment

Getting to Undetectable: People Living With HIV Share Their Stories

HIV Management Today: Mental Health & HIV, the Uncharted Territory

Get TheBody.com in the Palm of Your Hand

No, HIV Is NOT About to Be Cured in Three Months

More >>

New! TheBody.com App

My Health Tracker

Medication and Health Reminders

Assess Your Risk for HIV

U.S. ASO Finder

The Body is a service of Remedy Health Media, LLC, 500 5th Avenue, 19th Floor, New York, NY 10110. The Body and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.